XBRANE BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2135 SEK | -1.39% |
|
-39.35% | -97.86% |
| Apr. 22 | Transcript : Xbrane Biopharma AB - Special Call | |
| Mar. 18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
Evolution of the average Target Price on Xbrane Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
2e0183f79dae7b9de36.0gORnLBD6qSaqkI5VAsUnySTSXuodrc65gwpzLaK36A.nW3d5IkH3uLFxjNOF1hH1mbCfz_APONZjHl9pfP6qZLqRvL9-DGZ8fGbGw~478c92a5670c182186aa4deff07fe8fe
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.2135
SEK
Average target price
0.625
SEK
Spread / Average Target
+192.74%
High Price Target
0.65
SEK
Spread / Highest target
+204.45%
Low Price Target
0.6
SEK
Spread / Lowest Target
+181.03%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- XBRANE Stock
- Consensus Xbrane Biopharma AB
